Home [sandbox] K4D COVID-19 Resource Hub Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items Dozens of coronavirus drugs are in development — what happens next?

Dozens of coronavirus drugs are in development — what happens next?

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-07-04

Type Journal Article Author Heidi Ledford URL https://www.nature.com/articles/d41586-020-01367-9 Rights 2020 Nature Series News Volume 581 Issue 7808 Pages 247-248 Publication Nature Date 14/05/2020 Extra Number: 7808 Publisher: Nature Publishing Group DOI 10.1038/d41586-020-01367-9 Accessed 2020-07-04 17:25:06 Library Catalog www.nature.com Language en Abstract Drug manufacturers face supply-chain weaknesses and sourcing issues as they ramp up complex production processes to meet global demand.